NCT06341062

Brief Summary

The goal of this study is to quantitatively assess renal microcirculation changes by contrast-enhanced ultrasound and to obtain systemic hemodynamic information by ultrasound Doppler at the same time, to analyze the relationship between renal microcirculation changes and systemic hemodynamic changes, and to explore its predictive value in renal function recovery in patients with critical acute kidney injury. The main questions it aims to answer are:

  1. 1.To explore the quantitative parameters of contrast-enhanced ultrasound which can reflect the changes of renal microcirculation.
  2. 2.To explore the relationship between renal microcirculation and systemic hemodynamics.
  3. 3.To explore the value of renal microflow changes quantitatively evaluated by contrast-enhanced ultrasound in predicting renal function recovery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for all trials

Timeline
2mo left

Started Apr 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Apr 2024Jun 2026

First Submitted

Initial submission to the registry

March 17, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 2, 2024

Completed
13 days until next milestone

Study Start

First participant enrolled

April 15, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

February 17, 2025

Status Verified

February 1, 2025

Enrollment Period

1.2 years

First QC Date

March 17, 2024

Last Update Submit

February 13, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Serum creatinine values and/or urine output

    Complete recovery (defined as a return to normal serum creatinine and urine volume) and reversal of acute kidney injury (AKI) (more than 50% improvement in serum creatinine and/or urine volume from baseline), non-recovery included persistent AKI(no significant improvement or further increase in serum creatinine and/or urine volume, the need for dialysis, or death.)

    Through study completion, an average of 7 days

Study Arms (2)

Patients recovering before hospital discharge

Recovery is defined as a return to normal serum creatinine and urine volume or more than 50% improvement in serum creatinine and/or urine volume from baseline

Patients not recovering before hospital discharge

Non-recovery is defined as no significant improvement or further increase in serum creatinine and/or urine volume, the need for dialysis, or death.

Other: Renal microcirculation quantitatively assessed by Contrast-enhanced ultrasound

Interventions

Renal microcirculation quantitatively assessed by Contrast-enhanced ultrasound before hospital discharge

Patients not recovering before hospital discharge

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Published contrast-enhanced ultrasound data from critically ill patients are limited. Through literature review, the area under the curve of contrast-enhanced ultrasound to predict kidney recovery in critically ill AKI patients is 0.72, and the width of confidence interval is 0.35. When α=0.05, the sample size N=34 is obtained by using PASS software. Considering the 20% shedding rate, 44 patients are expected to be enrolled in this study.

You may qualify if:

  • Age \>18 years old;
  • AKI was diagnosed \< 24 hours after first admission to intensive care unit (ICU) and the expected length of stay in ICU ≥48 hours;
  • Meet Kidney Disease Improving Global Outcomes (KDIGO) 2012 diagnostic criteria for acute kidney injury;
  • Contrast-enhanced ultrasound was performed within 24 hours after diagnosis of acute kidney injury (AKI).

You may not qualify if:

  • Known severe chronic kidney disease (CKD≥ stage 4) or undergoing hemodialysis treatment;
  • Kidney transplantation or renal malignancy;
  • Terminal stage of malignant tumor;
  • Pregnancy;
  • Renal artery stenosis or renal vein thrombosis;
  • Allergy to contrast agent SonoVue(BraccoSpA, Milan, Italy) or its components, or the presence of severe cardiopulmonary insufficiency (e.g., right-to-left shunt heart disease or pulmonary systolic blood pressure \>90mmHg).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Ultrasound Diagnosis, Peking University Third Hospital

Beijing, Beijing Municipality, China

RECRUITING

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Ligang Cui, Dr

    Department of Ultrasound, Peking University Third Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yuewei Zhang, Dr

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Physician

Study Record Dates

First Submitted

March 17, 2024

First Posted

April 2, 2024

Study Start

April 15, 2024

Primary Completion

June 30, 2025

Study Completion (Estimated)

June 30, 2026

Last Updated

February 17, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations